The 11 closest competitors and alternatives to Tvaster Genkalp among therapeutic devices companies — ranked by similarity to what Tvaster Genkalp actually does, not by market-cap band.
Subscribe to see Tvaster Genkalp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tvaster Genkalp Pvt. Ltd. is a molecular diagnostics company established in May 2021 and headquartered in Chennai, Tamil Nadu. The company specializes in liquid biopsy, offering blood-based cancer diagnostic solutions.
Tvaster Genkalp is a therapeutic devices company headquartered in India. Its most recent funding round, Pre-Series A, raised $1.3M in April 2025. Xcout tracks 2 named people at Tvaster Genkalp, including K. Sreedurgalakshmi (co-founder).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | $1.3M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Tvaster Genkalp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Devices
3B BlackBio Dx Limited is a biotechnology research and diagnostic solutions company based in Bhopal, Madhya Pradesh, India, providing molecular solutions for oncology and infectious diseases.
Medical Device
AnchorDx is a public biotechnology company headquartered in Guangzhou, China, with additional research and production facilities in the United States. The company specializes in the development of advanced cancer screening and early diagnostic solutions utilizing genomic and molecular technologies. Their products target precision medicine and oncology markets globally.
Diagnostic Equipment
Amplifold AI Private Limited is an Indian company based in Bangalore that is developing DNA-origami-enabled signal amplification technology for rapid diagnostics.
Medical Devices
CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood. Specifically, the PC1 system is designed for metastatic breast cancer samples, facilitating subsequent user-validated downstream analysis. CelLBxHealth also provides the Portrait+ CTC Staining kit, a laboratory solution for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs with high analytical sensitivity and specificity, alongside the CellKeep Slide technology for CTC harvesting. In addition to these products, the company delivers a suite of laboratory services, including CTC enrichment and liquid biopsy analysis. Specialized assays are also available, such as Portrait Flex for immunofluorescence-based identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition, Portrait PD-L1 for CTC evaluation, and bespoke custom CTC assays. Furthermore, CelLBxHealth plc has forged strategic alliances, including a partnership with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. for the application of its pan-cancer next-generation sequencing (NGS) panel.
Biotech, Medical Devices
Genomictree Inc. is a healthcare sector company headquartered in Daejeon, South Korea, founded in 2000. The company focuses on developing products like the EarlyTect colon cancer screening test.
Health Care Equipment & Services
INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
Diagnostic Equipment
Vital Bio is a biotechnology research company based in Oakville, Ontario, dedicated to developing advanced healthcare diagnostic and blood-testing technologies.
Medical Devices
Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.
Medical Devices, Diagnostics
Astrego Diagnostics AB is a Swedish company headquartered in Uppsala, Sweden. Founded in March 2017 based on research from Uppsala University, it develops diagnostic solutions and has become a wholly-owned subsidiary of Sysmex Corporation.
Diagnostic Equipment
Botanisol Analytics is a private biotechnology company founded in 2017 that develops molecular detection instrumentation and autonomous testing kiosks for diagnostic, forensic, pharmaceutical, agricultural, and bioproduction applications.
Health Care Equipment & Services
Rhythm Biosciences Limited functions as a forward-thinking enterprise focused on predictive cancer diagnostics, active across both Australian and global territories. The company's core operations involve the creation, advancement, and market introduction of cutting-edge medical diagnostic technologies. A key innovation is ColoSTAT, their specialized blood test designed for the prompt and reliable identification of colorectal cancer. Established in 2017, the firm's main offices are located in Parkville, Australia.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tvaster Genkalpand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →